Evolent Health, Inc. (EVH)

Evolent Health, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Evolent Health, Inc. (EVH) is a Medical - Healthcare Information Services company based in US with a market capitalization of $443.7M. Revenue declined 26.6% year-over-year and the company generated $4.8M in free cash flow. This page tracks EVH's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 4.5K employees · IPO Jun 5, 2015

Valuation

Valuation & price

$3.96as of May 17, 2026· -66.4% vs 52w high

P/E ratio

Latest-FY diluted EPS

1.07

P/B ratio

Market cap ÷ book equity

Dividend yield

Price — last 12 months

$11.64$6.93$2.21Jul 25Dec 25Jul 26
$2.1752-week range$11.78
Loading valuation history…

Fundamentals

Key fundamentals

$443.7M

Market cap

-26.6%

Revenue growth (YoY)

15.1%

Gross margin

$4.8M

Free cash flow (USD)

$837.8M

Net debt

-0.4%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

20162025

$254.2M$1.9B

Free cash flow by year

20162025

-$51M$4.8M

Gross margin by year

20212025

27.6%15.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventJun 4, 2026Filing

    Annual Meeting Results

  • 8-K eventMay 7, 2026Filing

    Earnings Release

  • Quarterly reportMay 7, 2026Filing

    10-Q Filed

Questions

Frequently asked questions

What is Evolent Health, Inc.'s market cap?

Evolent Health, Inc. (EVH) has a market capitalization of $443.7M.

What is EVH's P/E ratio?

A meaningful P/E ratio is not available for EVH — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is EVH's price-to-book (P/B) ratio?

EVH trades at 1.07 times book value per share.

Are insiders buying EVH stock?

SEC Form 4 filings show no open-market insider buys at Evolent Health, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Healthcare Information Services

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.